Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05396287 Enrolling by invitation - Healthy Clinical Trials

Blood Vessel Anatomy and Blood Flow Regulation

Start date: July 19, 2022
Phase:
Study type: Observational

Brain blood flow regulation will be measured in response to environmental changes using MRI.

NCT ID: NCT05394155 Completed - Healthy Clinical Trials

Leucine Requirement in Adult Men and Women

Start date: April 29, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the body's nutritional need for the essential amino acid, leucine, in adult men and women 18 to 39 years of age.

NCT ID: NCT05393856 Completed - Healthy Clinical Trials

CG-549 Tablet Pharmacokinetics Study

Start date: September 23, 2019
Phase: Phase 1
Study type: Interventional

This will be an open label, crossover, single dose study consisting of 2 parts (Part A and Part B) in a total of 24 healthy male and female subjects.

NCT ID: NCT05393115 Recruiting - Healthy Clinical Trials

Respiratory Muscle Fatigue at Different Breathing Modes

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

The study aims at investigating if time to respiratory muscle fatigue and metabolism are influenced by the pressure wave form mode applied during resistive breathing.

NCT ID: NCT05392816 Completed - Healthy Clinical Trials

Non-heme Iron Absorption From Single Meals of Fava Bean Protein, Beef Protein and Cod Protein

Start date: September 6, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the non-heme iron absorption from single meals of texturized fava bean protein, which has been suggested as a protein source suitable for replacement of meat, compared to the non-heme iron absorption from beef protein and cod protein meals. The study participants are women of fertile ages, which is one of the main groups at risk of developing iron deficiency. Since a dietary shift towards increasingly plant based is being pushed, investigating nutritional effects of such a shift is essential to avoid potential negative effects such as an increase of nutritional deficiencies. The study includes two cross-over single-blinded iron isotope trials in apparent healthy Swedish women of the ages 18-45 years, each of whom served as their own control. Participants will be served matched test meals containing beef and fava bean protein (Study 1), or cod and fava bean protein (Study 2) with radiolabeled non-heme iron 55Fe and 59Fe. Absorption of non-heme iron from test meals will be measured by whole-body counting, and erythrocyte incorporation by liquid scintillation.

NCT ID: NCT05392530 Completed - Healthy Clinical Trials

A Study of Two Different Test Formulations Compared to the Reference Formulation of Macitentan in Healthy Adult Participants

Start date: May 25, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the rate and extent of absorption of a single oral dose of macitentan given as 2 test formulations compared to the reference formulation under fed conditions in healthy adult participants.

NCT ID: NCT05390359 Completed - Healthy Clinical Trials

Bioimpedance and Sensorimotor Effects of Percutaneous Electrolysis Protocols on the Patellar Tendon

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Percutaneous electrolysis is a physical therapy technique, whose main objective is the treatment of the signs and symptoms associated with tendinopathies by applying a galvanic current through a blunt dry needle. Despite its clinical use being already stablished, the physiological mechanisms underlying this therapy are still unknown and thus, the optimal parameterization. The present study proposes to perform different stimulation protocols of percutaneous electrolysis on healthy subjects patellar tendon to answer those questions.

NCT ID: NCT05389150 Completed - Healthy Clinical Trials

Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects

Start date: January 17, 2019
Phase: Phase 1
Study type: Interventional

The study was carried out in the Clinical Unit and Analytical Unit of the Department of Pharmacology and Toxicology of the Faculty of Medicine of the Universidad Autónoma de Nuevo León, with the aim of comparing the bioavailability (maximum concentration and area under the curve) of an oral formulation containing Pregabalin 150 mg/Tramadol 50 mg in combination with the two oral formulations Pregabalin 150 mg or Tramadol 50 mg administered as a single dose, in healthy subjects under fasting conditions.

NCT ID: NCT05388201 Completed - Healthy Clinical Trials

Variation In Facial Morphology As A Determinant Of Face Covering Performance: FACEFIT

FACEFIT
Start date: June 1, 2022
Phase:
Study type: Observational

This study examines the role of variations in the dimensions of facial features on the fitted filtering efficiency of face coverings available to the public during the COVID-19 pandemic. Approximately 100 young (18-55 years old) healthy participants will be recruited. Exclusionary criteria include pregnancy and breastfeeding. After informed consent, participants will enter a chamber where they will undergo 3D facial scanning using a dedicated camera system and be trained to don an N95 respirator properly. The fitted filtering efficiency (FFE) of 4 types of face coverings: a N95 respirator, a KN95 respirator (with and without a clip), a surgical mask (with and without a clip), and a KF94 respirator (with and without a clip) will be tested on each participant using the OSHA quantitative fit testing protocol for filtering face pieces.

NCT ID: NCT05387759 Completed - Healthy Clinical Trials

A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants

Start date: May 30, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the effects of aticaprant on QT/ QT interval corrected for heart rate (HR) (QTc) intervals and electrocardiogram (ECG) morphology at therapeutic and supratherapeutic exposures in healthy adult participants.